| 01/09/26 | 07:00:10 | 1 Sept 2026 | | Total Voting Rights | RNS |
| 14/08/26 | 10:48:27 | 14 Aug 2026 | | Admission to Trading | RNS |
| 11/08/26 | 09:12:00 | 11 Aug 2026 | | Admission to Trading Application | RNS |
| 07/08/26 | 07:00:06 | 7 Aug 2026 | | Half Year Trading Update and Notice of Results | RNS |
| 03/08/26 | 07:00:04 | 3 Aug 2026 | | Total Voting Rights | RNS |
| 23/07/26 | 14:21:31 | 23 Jul 2026 | | Holding(s) in Company | RNS |
| 16/07/26 | 12:00:00 | 16 Jul 2026 | | OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme | GNW |
| 16/07/26 | 07:00:04 | 16 Jul 2026 | | Manufacturing agreement with Plowshare Therapies | RNS |
| 14/07/26 | 14:45:34 | 14 Jul 2026 | | Holding(s) in Company | RNS |
| 08/07/26 | 17:57:49 | 8 Jul 2026 | | Holding(s) in Company | RNS |
| 01/07/26 | 07:00:02 | 1 Jul 2026 | | Total Voting Rights | RNS |
| 22/06/26 | 10:10:05 | 22 Jun 2026 | | Admission to Trading | RNS |
| 17/06/26 | 08:10:18 | 17 Jun 2026 | | Admission to trading application | RNS |
| 02/06/26 | 07:00:05 | 2 Jun 2026 | | OXB Capital Markets Event | RNS |
| 02/06/26 | 07:00:00 | 2 Jun 2026 | | OXB Capital Markets Event | GNW |
| 01/06/26 | 07:00:04 | 1 Jun 2026 | | Total Voting Rights | RNS |
| 27/05/26 | 07:00:06 | 27 May 2026 | | Director Declaration | RNS |
| 22/05/26 | 14:17:24 | 22 May 2026 | | Director/PDMR Shareholding | RNS |
| 19/05/26 | 09:56:29 | 19 May 2026 | | PDMR Dealing | RNS |
| 13/05/26 | 10:52:07 | 13 May 2026 | | PDMR Dealing | RNS |
| 08/05/26 | 12:00:00 | 8 May 2026 | | OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT) | GNW |
| 07/05/26 | 16:58:16 | 7 May 2026 | | Result of AGM | RNS |
| 01/05/26 | 07:00:04 | 1 May 2026 | | Total Voting Rights | RNS |
| 30/04/26 | 08:15:00 | 30 Apr 2026 | | Admission to Trading | RNS |
| 27/04/26 | 09:51:37 | 27 Apr 2026 | | Admission to Trading Application | RNS |
| 13/04/26 | 07:00:09 | 13 Apr 2026 | | Launch of viral vector fast-track offering | RNS |
| 08/04/26 | 17:18:41 | 8 Apr 2026 | | Grant of Awards | RNS |
| 01/04/26 | 07:00:03 | 1 Apr 2026 | | Total Voting Rights | RNS |
| 30/03/26 | 15:30:31 | 30 Mar 2026 | | 2026 Annual General Meeting notification | RNS |
| 26/03/26 | 07:00:06 | 26 Mar 2026 | | Preliminary results for the year ended 31 Dec 2025 | RNS |
| 18/03/26 | 07:00:12 | 18 Mar 2026 | | Licensing agreement with VVMF | RNS |
| 09/03/26 | 07:53:49 | 9 Mar 2026 | | Admission to Trading | RNS |
| 04/03/26 | 11:45:00 | 4 Mar 2026 | | Admission to Trading Application | RNS |
| 03/03/26 | 07:00:10 | 3 Mar 2026 | | Capital Markets Day and investor conferences | RNS |
| 02/03/26 | 07:00:04 | 2 Mar 2026 | | Total Voting Rights | RNS |
| 25/02/26 | 12:33:16 | 25 Feb 2026 | | Response to Rule 2.8 Announcement | RNS |
| 24/02/26 | 07:03:59 | 24 Feb 2026 | | Full year Trading Update and Notice of Results | RNS |
| 19/02/26 | 09:44:42 | 19 Feb 2026 | | Rule 2.9 Announcement | RNS |
| 11/02/26 | 15:01:22 | 11 Feb 2026 | | Extension of PUSU Deadline | RNS |
| 06/02/26 | 07:00:09 | 6 Feb 2026 | | Rule 2.9 Announcement | RNS |
| 05/02/26 | 07:00:09 | 5 Feb 2026 | | Rule 2.9 Announcement | RNS |
| 04/02/26 | 07:00:01 | 4 Feb 2026 | | Multi-year supply agreement with BMS | RNS |
| 02/02/26 | 07:00:07 | 2 Feb 2026 | | Total Voting Rights | RNS |
| 29/01/26 | 07:00:10 | 29 Jan 2026 | | Rule 2.9 Announcement | RNS |
| 27/01/26 | 13:29:35 | 27 Jan 2026 | | Form 8 - Oxford Biomedica plc | RNS |
| 26/01/26 | 07:00:07 | 26 Jan 2026 | | Rule 2.9 Announcement | RNS |
| 22/01/26 | 07:00:08 | 22 Jan 2026 | | Rule 2.9 Announcement | RNS |
| 19/01/26 | 07:00:06 | 19 Jan 2026 | | Rule 2.9 Announcement | RNS |
| 14/01/26 | 16:49:27 | 14 Jan 2026 | | Response to press speculation | RNS |
| 02/01/26 | 07:00:05 | 2 Jan 2026 | | Block Listing Return | RNS |
